Coenzyme Q10 supplementation can reduce systolic blood pressure

Summary An analysis of 12 clinical trials investigated the correlation between coenzyme Q10 supplementation, a cofactor of cellular energy metabolism, and hypertension. Based on all results, the researchers concluded that coenzyme Q10 supplementation can reduce systolic blood pressure by up to 17 points (mmHg) and diastolic blood pressure by up to 10 points. Among the…

Benefits of coenzyme Q 10 in hypertensive patients

Summary This study was undertaken to clarify the mechanism of the antihypertensive effect of coenzyme Q10 (CoQ10). Ten patients with essential arterial hypertension were treated with oral CoQ10 50 mg twice daily for ten weeks. Plasma CoQ10, serum total and high-density lipoprotein (HDL) cholesterol, serum sodium and potassium, plasma clinostatic and orthostatic renin activity, urinary…

Coenzyme Q10 can replace conventional pharmaceutical therapies in patients with hypertension

Summary A total of 109 patients with symptomatic essential hypertension presenting to a private cardiology practice were observed after the addition of CoQ10 (average dose, 225 mg/day by mouth) to their existing antihypertensive drug regimen. In 80 per cent of patients, the diagnosis of essential hypertension was established for a year or more prior to…